Breaking News
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

image_pdfDownload PDFimage_print

An interview with Professor Jack Gilbert, conducted by Alina Shrourou, BSc.

What is a microbiome and why are microbiomes unique to an individual?

A microbiome is the sum total of the microbes of bacteria, fungi, and viruses that live inside your body. They are all over your skin and in your gut. Bacteria alone accounts for 2-3 lbs of your body mass.

© vrx/Shutterstock.com

What’s interesting is that when you’re born, you’re mostly sterile. You acquire microbes from your mother and the environment. Then, the way you live your life and the things you interact with shape the kind of microbes that colonize and live inside you. This results in your own unique profile, and even identical twins have different profiles.

Please outline the Burglary Microbiome Project that you discussed at Pittcon 2018.

We’ve been trying to understand if our bacterial signature can act like a fingerprint, and be used as some kind of forensic tool, like trace evidence.

We emit around 36 million bacterial cells into our immediate environment every single hour – so if a burglar in a room for 10 minutes touches objects and leaves behind some their bacteria, can we detect their personal bacterial signature by obtaining some of the bacteria present in the room?

It could then be possible to sequence the information, as we do with human DNA at a crime scene, and therefore identify that individual.

It’s an interesting idea, and at the moment it’s a very early research project that we’re working on with the National Institute of Justice.

How do you determine whether a microbial organism is associated with a particular trait?

We’ve been trying to see if the bacterial signature that lives inside us is somehow correlated with our lifestyle choices.

The signature that belongs to you is very much determined by how you’ve lived your life; whether you had pets growing up, whether you grew up in a city or a farm etc, are all factored in.

Different working environments can determine what bacteria live inside you, how they grow and how they’re distributed, so we wanted to see if that correlates. We built up a database of over 12,000 people and we’ve been correlating how similar our mock burglars microbiome signatures are to people in our database. It’s complicated, but we’re getting really close to identifying somebody’s lifestyle traits based on the microbial signature they leave behind at a crime scene.

What analytical techniques are you using to identify microbial biomarkers?

We leverage genome sequencing, especially the Illumina platforms – DNA extraction, and PCR amplification, much the same way as we would with human DNA sequences. We identify a particular gene present in all bacteria which we then sequence and use to determine which bacterial organisms are present in different subjects and what makes an individual unique.

We then produce a probability estimate that your bacteria would be found in a certain environment. Using advanced statistical techniques, we try and identify whether your bacteria’s sequencing data can place you at that crime scene.

Please outline any specific biomarkers that you have already identified in this project.

The way in which we analyze the microbiota is by looking for unique strains of organisms. We all have one particular species of E. coli living inside our gut, and we all have Staphylococcus epidermidis living in our skin, but each individual has a strain with a genotype and genome unique to them. It evolves with you and mutates over time, and we call those mutations biomarkers.

We’re using that information to try and identify whether we can pull out particular genotypic mutations, or biomarkers, which are unique to an individual.

If an individual’s lifestyle can change throughout their lifetime, does this mean that their microbiome can too? If so, are microbiome signatures always an accurate identification tool?

We are trying to answer a very particular question; whether the microbiome profile of an individual is stable and stays with you throughout your life.

We hypothesize based on all the data we’ve collected that we have a unique strain based composition which is a fingerprint of our microbiota, but we haven’t proved this, and there are lots of factors that could alter this theory.

Part of this project is to try and identify whether our microbial fingerprint stable, and how stable it is. Once you leave a trace of your bacteria signature on a doorknob or television set, does it decay? And if so, how rapidly?

What do you think the future holds for using an individual’s unique microbiome in this way? Or for other applications?

The future is really exciting. We can potentially use the microbiome in forensic science, but that would be in the distant future. The human DNA program for forensic evidence took decades, and we’re only just starting our journey.

What’s most exciting is we can also use the microbiome information inside our bodies in personalized medicine, using the microbiome to predict whether an individual will respond to a particular therapy.

We could screen a cancer patient’s microbiome and determine if they have the biomarkers that can indicate their response to immunotherapy, which can help health care professionals identify their ideal strategy for therapy. We can use this to tailor treatment to the individual rather than the average treatment of a population.

How can Pittcon 2018 help you with your research?

What’s exciting about Pittcon is that it brings together a whole group of technological experts in areas that I wouldn’t normally have access to.

Being able to access the breadth of experience and technologies that are available to me here gives me more opportunities to expand my research objectives and to do something novel and exciting, that perhaps I wouldn’t normally have the chance to be involved in.

About Prof. Jack Gilbert

Professor Jack A Gilbert earned his Ph.D. from Unilever and Nottingham University, UK in 2002, and received his postdoctoral training at Queens University, Canada. He subsequently returned to the UK in 2005 to Plymouth Marine Laboratory at a senior scientist until his move to Argonne National Laboratory and the University of Chicago in 2010.

Currently, Professor Gilbert is the Director of the Microbiome Center and a Professor of Surgery at the University of Chicago. He is also Group Leader for Microbial Ecology at Argonne National Laboratory, Research Associate at the Field Museum of Natural History, Scientific Fellow at the Marine Biological Laboratory, and the Yeoh Ghim Seng Visiting Professorship in Surgery at the National University of Singapore.

Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He has authored more than 250 peer reviewed publications and book chapters on metagenomics and approaches to ecosystem ecology. He is the founding Editor in Chief of mSystems journal. In 2014 he was recognized on Crain’s Business Chicago’s 40 Under 40 List, and in 2015 he was listed as one of the 50 most influential scientists by Business Insider, and in the Brilliant Ten by Popular Scientist.

In 2016 he won the Altemeier Prize from the Surgical Infection Society, and the WH Pierce Prize from the Society for Applied Microbiology for research excellence. He also co-authored “Dirt is Good” published in 2017, a popular science guide to the microbiome and children’s health.

Tagged with:

About author

Related Articles